ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2132

The Bridge to Adult Care from Childhood for Young Adults with Rheumatic Disease (BACC YARD) Program, a Pediatric-To-Adult Rheumatology Transition Program, Reduces Median Time between Final Pediatric, First Adult, and Second Adult Visits

Ayah Eltoum1, Eileen Rife2, Livie Timmerman3, Emily Smitherman4, Melissa Mannion4 and John Bridges5, 1University of Alabama at Birmingham, Hoover, AL, 2University of Alabama Birmingham, Vestavia Hills, AL, 3University of Alabama at Birmingham, Gardendale, AL, 4University of Alabama at Birmingham, Birmingham, AL, 5University of Alabama at Birmingham/Children's of Alabama, Birmingham, AL

Meeting: ACR Convergence 2025

Keywords: Access to care, Juvenile idiopathic arthritis, Pediatric rheumatology, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 28, 2025

Title: (2124–2158) Pediatric Rheumatology – Clinical Poster III

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: The transition from pediatric to adult-oriented rheumatology care is a critical period for young adults with childhood-onset rheumatic diseases. The Bridge to Adult Care from Childhood for Young Adults with Rheumatic Disease (BACC YARD) Program offers a dual provider pre-transfer visit to facilitate successful transition. This study evaluates whether the dual provider pre-transfer visit improves intervals for subsequent adult rheumatology visits, compared to historical controls without a formal pre-transfer visit.

Methods: We conducted a retrospective cohort study of 189 young adults with childhood-onset rheumatic disease who transferred from Children’s of Alabama to the University of Alabama, Birmingham adult rheumatology clinic. The intervention group (n=144) enrolled in the BACC YARD Program between July 2020-April 2024 and completed a dual provider pre-transfer visit. The historical control group (n=45) transferred between March 2018-February 2020 without a structured pre-transfer visit. The primary exposure was participation in the BACC YARD program and the primary outcome was the number of days from the last pediatric visit to the first adult visit. Secondary outcomes included the interval (in days) between first and second adult visits, and adherence to provider-recommended follow-up intervals. Wilcoxon rank-sum and Kruskal-Wallis tests were used to compare median intervals between groups. Logistic regression models were used to estimate associations between successful adherence to provider-recommended intervals, adjusted for age, sex, race, ethnicity, and diagnosis in the BACC YARD group.

Results: The median age was 20 years in both cohorts. Females comprised 75% of the BACC YARD group and 89% of the control group. Juvenile idiopathic arthritis (JIA) was the most common diagnosis (56%, n=105) in both cohorts, followed by systemic lupus erythematosus (SLE) (30%, n=56). The BACC YARD group demonstrated significantly shorter median time from the last pediatric to the first adult visit compared to controls (143 vs. 261 days, p=0.0049), particularly among patients with JIA (148 vs. 316 days, p=0.0145). No significant difference was observed for patients with SLE. Among the BACC YARD group, the median interval between the first and second adult visits was 148 days (range: 22 to 605), with no significant differences across diagnosis groups. 71% (n=102) had their first adult visit within 30 days of their recommended follow-up date with no factors significantly associated with first visit adherence. 58% (n=83) had a second visit within 30 days of their recommended follow-up date. Hispanic patients were 80% less likely to adhere to the second visit compared to non-Hispanic patients (OR= 0.2, 95% CI: 0.05-0.90, p=0.035).

Conclusion: Participation in the BACC YARD program was associated with a shorter time interval to initial adult rheumatology clinic visit, particularly for patients with JIA. While most patients in the program continued to adhere to recommended timing for follow-up, disparities were observed by ethnicity in second visit adherence. These findings support embedding pre-transfer coordination into transition models to improve continuity for adolescents with rheumatic disease.

Supporting image 1Table 1: Patient Characteristics, BACC YARD and Historical Control Cohorts

Supporting image 2Table 2: Days from last pediatric visit to first adult visit, BACC YARD Cohort vs Historical Control Cohort

Supporting image 3Table 3: Days from first to second adult visit, BACC YARD Cohort (7/2020-4/2024, N&#3f144)


Disclosures: A. Eltoum: None; E. Rife: None; L. Timmerman: None; E. Smitherman: None; M. Mannion: None; J. Bridges: None.

To cite this abstract in AMA style:

Eltoum A, Rife E, Timmerman L, Smitherman E, Mannion M, Bridges J. The Bridge to Adult Care from Childhood for Young Adults with Rheumatic Disease (BACC YARD) Program, a Pediatric-To-Adult Rheumatology Transition Program, Reduces Median Time between Final Pediatric, First Adult, and Second Adult Visits [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/the-bridge-to-adult-care-from-childhood-for-young-adults-with-rheumatic-disease-bacc-yard-program-a-pediatric-to-adult-rheumatology-transition-program-reduces-median-time-between-final-pediatric/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-bridge-to-adult-care-from-childhood-for-young-adults-with-rheumatic-disease-bacc-yard-program-a-pediatric-to-adult-rheumatology-transition-program-reduces-median-time-between-final-pediatric/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology